Pharmacosmos develops and markets medicines for the treatment of
iron deficiency. An independent pharmaceutical company with an
ongoing R&D programme, our goal is to improve iron therapy
options for patients and healthcare professionals.
Our second focus area, we develop and market high quality
dextran biopolymers for pharmaceutical and life science
Read more about our company and